• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

GE unveils new cardiovascular ultrasound

Article

At this month’s Society of Echocardiography meeting in Chicago, GE Medical Systems showed a new cardiovascular ultrasound system named the Vivid FiVe. GE officials said this is the first ultrasound system on the market to offer a myocardial

At this month’s Society of Echocardiography meeting in Chicago, GE Medical Systems showed a new cardiovascular ultrasound system named the Vivid FiVe. GE officials said this is the first ultrasound system on the market to offer a myocardial tissue visualization technique called “tissue tracking.”

The tool aids cardiologists in the diagnosis and monitoring of coronary artery disease.

Vivid FiVe was preceded by the Vingmed System FiVe in GE’s line of cardiovascular ultrasound products, and is an upgrade to this system. The Vivid FiVe includes three new features: tissue tracking, contrast imaging with real-time myocardial contrast, and four-dimensional imaging.

Tissue tracking provides more accurate imaging of the heart, contrast imaging allows clinicians to study myocardial perfusion, and 4-D imaging occurs when clinicians apply 2-D digital data to construct a 4-D model of cardiac functions.

Recent Videos
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Can 18F-Floutufolastat Bolster Detection of PCa Recurrence in Patients with Low PSA Levels After Radical Prostatectomy?
2 KOLs are featured in this series.
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.